AA amyloidosis associated with morbid obesity (clinical case)

Reumatol Clin (Engl Ed). 2020 Nov-Dec;16(6):493-496. doi: 10.1016/j.reuma.2018.09.001. Epub 2018 Dec 4.
[Article in English, Spanish]

Abstract

We present the case of a 45-year-old woman who was hospitalized due to severe macrocytic anemia and renal failure. The patient presented a morbid obesity. The immunological study showed anti-ENA anti-SSA (Ro52) positive, with negative antinuclear antibodies. Also in the proteinogram (serum immunofixation) the presence of monoclonal bands IgG lambda and IgG kappa, monoclonal component 7.2% (4.68g/L), with elevation of free light chains (kappa 95.94mg/L (3.3-19.4), evidenced, lambda 145.17mg/L (5.71-26.3)). The bone marrow study showed an infiltration of 5% of plasma cells and positive for AA amyloid. Finally, a percutaneous renal biopsy was performed, which again showed amyloid infiltration. In the genetic study, 2 mutations of the family Mediterranean fever gene (MEFV) have been identified. Secondary AA amyloidosis has been described associated with obesity, in addition to a percentage of cases of unknown etiology.

Keywords: Amiloidosis; Amyloidosis; Familial Mediterranean fever; Fiebre Mediterránea Familiar; Obesidad; Obesity.

Publication types

  • Case Reports

MeSH terms

  • Amyloidosis / etiology*
  • Female
  • Humans
  • Middle Aged
  • Obesity, Morbid / complications*
  • Serum Amyloid A Protein

Substances

  • Serum Amyloid A Protein

Supplementary concepts

  • AA amyloidosis